We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Sandwich Biosensor Developed for Tuberculosis Diagnosis and Screening

By LabMedica International staff writers
Posted on 07 Jun 2015
Print article
Researchers have developed a system that could quickly and reliably identify people infected with Mycobacterium tuberculosis and simultaneously differentiate from those who have received the bacillus Calmette-Guerin (BCG) vaccine for tuberculosis (TB).

Early identification is required to reduce the growing worldwide healthcare burden of TB. One of the biggest hurdles is to differentiate people infected with TB from those who have received the BCG vaccine. An international research team from Malaysia and Iran, led by Taha Roodbar Shojaei and Mohamad Amran Mohd Salleh of Universiti Putra Malaysia (Selangor, Malaysia), have developed a layered biosensor using modified quantum dots, gold nanoparticles, and single-strand DNAs (two specific oligonucleotides against early secretory antigenic target 6). The sensor not only detects TB in patient sputum but also differentiates positive results from samples of vaccinated people. The sensor requires small amounts of sputum and could therefore be used where limited sample volumes are available.

Using the new sensor, the team has conducted preliminary tests on 50 clinical samples from patients in Tehran who were suspected of having TB. While current PCR-based diagnostic TB tests have an approximately 80% success rate for both sensitivity and specificity, the sensor test (based on this initial sample set) had 94.2% sensitivity and 86.6 % specificity. Its unique advantages in terms of turnaround time, higher sensitivity and specificity, as well as a lower (10-fold) detection limit would recommend this test as a more appropriate and cost-effective tool for large scale operations.

In 2015, the team is working to further enhance the biosensor with carbon nanoparticles instead of gold. They also plan to develop the device and interface to further simplify detection, perhaps with a smartphone app.

The report, by Shojaei TR, et al, was published in the November-December 2014 issue of the Brazilian Journal of Infectious Diseases.

Related Links:

Universiti Putra Malaysia


Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Rocking Shaker
HumaRock
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.